NCT02937857 - An Add-on Study to Evaluate the Efficacy and Safety of Xiyanping Injection in Pediatric Bronchitis Patients. | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

April 30, 2020

Study Completion Date

August 31, 2020

Conditions

Bronchitis

Interventions

DRUG

Standard treatment only

standard treatment， such as antiasthmatic,expectorant,antipyretic

DRUG

Standard treatment+Xiyanping injection

standard treatment+Xiyanping injection:standard treatment， such as antiasthmatic, expectorant and antipyretic plus Xiyanping injection,0.2-0.4mL/kg/day,qd for 5 days.

Trial Locations (1)

510623

RECRUITING

Guangzhou women and children health care center, Guangzhou